The increase of CD57+ T cells in the peripheral blood and their impaired immune functions in patients with advanced gastric cancer.

Authors:
  • TITakashi Ichikura
    Takashi Ichikura
  • TMTakashi Majima
    Takashi Majima
  • TKToshinobu Kawabata
    Toshinobu Kawabata
  • AMAtsushi Matsumoto
    Atsushi Matsumoto
  • HSHidekazu Sugasawa
    Hidekazu Sugasawa
  • NKNobuaki Kawarabayashi
    Nobuaki Kawarabayashi
  • ETEiji Takayama
    Eiji Takayama
  • HHHoshio Hiraide
    Hoshio Hiraide
  • SSShuhji Seki
    Shuhji Seki
  • HMHidetaka Mochizuki
    Hidetaka Mochizuki
Publisher website
Google Scholar
Abstract
In addition to natural killer (NK) cells, T cells expressing natural killer cell markers, CD56 or CD57 (NK type T cells), have been considered to play an important role in antitumor immunity. We examined the proportion of NK cell and NK type T cell subsets in the peripheral blood from patients with gastric cancer. The IFN-gamma production capacity and population of cytoplasmic perforin positive cells in peripheral blood mononuclear cells (PBMC) were evaluated. Peripheral blood samples were obtained from 56 patients with gastric cancer and 21 healthy volunteers. The proportion of CD56- CD57+ T cells (CD57+ T cells) was significantly higher in advanced gastric cancer patients than those in healthy volunteers and patients with early stage gastric cancer, whereas no correlation was observed between the proportion of CD56+ T cells or NK cells and tumor progression. Furthermore, a significant decrease of CD8+ CD57+ T cells was found in patients with advanced gastric cancer. The proportion of CD57+ T cells did not correlate with interferon-gamma (IFN-gamma) production from PBMC in gastric cancer patients, although a significant correlation was found between them in healthy volunteers. The proportion of perforin positive CD57+ T cells, especially CD8+ CD57+ T cells, in patients with gastric cancer was markedly lower than that in healthy volunteers. Collectively, although the proportion of CD57+ T cells in PBMC was found to increase with tumor progression, their function in antitumor immunity is impaired in patients with gastric cancer.